AU2002365511A1 - Quinoline derivatives, process for preparing them and use for the treatment of diseases mediated by s-cd23 - Google Patents
Quinoline derivatives, process for preparing them and use for the treatment of diseases mediated by s-cd23Info
- Publication number
- AU2002365511A1 AU2002365511A1 AU2002365511A AU2002365511A AU2002365511A1 AU 2002365511 A1 AU2002365511 A1 AU 2002365511A1 AU 2002365511 A AU2002365511 A AU 2002365511A AU 2002365511 A AU2002365511 A AU 2002365511A AU 2002365511 A1 AU2002365511 A1 AU 2002365511A1
- Authority
- AU
- Australia
- Prior art keywords
- preparing
- treatment
- diseases mediated
- quinoline derivatives
- quinoline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 229940027991 antiseptic and disinfectant quinoline derivative Drugs 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 230000001404 mediated effect Effects 0.000 title 1
- 125000002943 quinolinyl group Chemical class N1=C(C=CC2=CC=CC=C12)* 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0128378.7 | 2001-11-27 | ||
| GBGB0128378.7A GB0128378D0 (en) | 2001-11-27 | 2001-11-27 | Novel Compounds |
| PCT/EP2002/013264 WO2003045938A1 (en) | 2001-11-27 | 2002-11-25 | Quinoline derivatives, process for preparing them and use for the treatment of diseases mediated by s-cd23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2002365511A1 true AU2002365511A1 (en) | 2003-06-10 |
Family
ID=9926525
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002365511A Abandoned AU2002365511A1 (en) | 2001-11-27 | 2002-11-25 | Quinoline derivatives, process for preparing them and use for the treatment of diseases mediated by s-cd23 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7045626B2 (https=) |
| EP (1) | EP1448552B1 (https=) |
| JP (1) | JP2005513036A (https=) |
| AR (1) | AR037427A1 (https=) |
| AT (1) | ATE334124T1 (https=) |
| AU (1) | AU2002365511A1 (https=) |
| DE (1) | DE60213450T2 (https=) |
| ES (1) | ES2268133T3 (https=) |
| GB (1) | GB0128378D0 (https=) |
| TW (1) | TW200303745A (https=) |
| WO (1) | WO2003045938A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005013964A1 (ja) | 2003-08-08 | 2005-02-17 | Ajinomoto Co., Inc. | ナテグリニド含有製剤 |
| EP2780015B1 (en) | 2011-11-18 | 2017-01-04 | Heptares Therapeutics Limited | Muscarinic m1 receptor agonists |
| JP6478923B2 (ja) | 2013-02-07 | 2019-03-06 | ヘプタレス セラピューティクス リミテッドＨｅｐｔａｒｅｓ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｌｉｍｉｔｅｄ | ムスカリンｍ４受容体アゴニストとしてのピペリジン−１−イル及びアゼピン−１−イルカルボキシレート |
| GB201404922D0 (en) | 2014-03-19 | 2014-04-30 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
| GB201513743D0 (en) | 2015-08-03 | 2015-09-16 | Heptares Therapeutics Ltd | Muscarinic agonists |
| GB201519352D0 (en) | 2015-11-02 | 2015-12-16 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
| GB201617454D0 (en) | 2016-10-14 | 2016-11-30 | Heptares Therapeutics Limited | Pharmaceutical compounds |
| GB201810239D0 (en) | 2018-06-22 | 2018-08-08 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
| GB201819961D0 (en) | 2018-12-07 | 2019-01-23 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
| GB201819960D0 (en) | 2018-12-07 | 2019-01-23 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
| GB202020191D0 (en) | 2020-12-18 | 2021-02-03 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL337854A1 (en) | 1997-07-31 | 2000-09-11 | Abbott Lab | Inverse hydroxamines as inhibitors of intercellular substance metaloproteinases |
| AU735929B2 (en) * | 1998-01-30 | 2001-07-19 | Darwin Discovery Limited | Hydroxamic and carboxylic acid derivatives |
-
2001
- 2001-11-27 GB GBGB0128378.7A patent/GB0128378D0/en not_active Ceased
-
2002
- 2002-11-25 US US10/496,193 patent/US7045626B2/en not_active Expired - Fee Related
- 2002-11-25 JP JP2003547388A patent/JP2005513036A/ja active Pending
- 2002-11-25 DE DE60213450T patent/DE60213450T2/de not_active Expired - Lifetime
- 2002-11-25 AR ARP020104526A patent/AR037427A1/es not_active Application Discontinuation
- 2002-11-25 ES ES02790436T patent/ES2268133T3/es not_active Expired - Lifetime
- 2002-11-25 WO PCT/EP2002/013264 patent/WO2003045938A1/en not_active Ceased
- 2002-11-25 EP EP02790436A patent/EP1448552B1/en not_active Expired - Lifetime
- 2002-11-25 AU AU2002365511A patent/AU2002365511A1/en not_active Abandoned
- 2002-11-25 AT AT02790436T patent/ATE334124T1/de not_active IP Right Cessation
- 2002-11-25 TW TW091134147A patent/TW200303745A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US7045626B2 (en) | 2006-05-16 |
| ATE334124T1 (de) | 2006-08-15 |
| JP2005513036A (ja) | 2005-05-12 |
| EP1448552B1 (en) | 2006-07-26 |
| DE60213450T2 (de) | 2007-09-20 |
| ES2268133T3 (es) | 2007-03-16 |
| GB0128378D0 (en) | 2002-01-16 |
| AR037427A1 (es) | 2004-11-10 |
| DE60213450D1 (de) | 2006-09-07 |
| TW200303745A (en) | 2003-09-16 |
| US20050085505A1 (en) | 2005-04-21 |
| WO2003045938A1 (en) | 2003-06-05 |
| EP1448552A1 (en) | 2004-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003233010A1 (en) | Process for the preparation of 3,3,4,4-tetrafluoropyrrolidine and derivatives thereof | |
| AU2002332430A1 (en) | Methods of treating neuropilin-mediated diseases | |
| AU2002348135A1 (en) | Methods for the treatment of addiction | |
| AU2001285747A1 (en) | Method for the treatment of tobacco | |
| AU2002252227A1 (en) | Heterocyclic derivatives for the treatment of cancer and other proliferative diseases | |
| AU2002329570A1 (en) | Method of monitoring neuroprotective treatment | |
| AU2002346611A1 (en) | Expression of glial-derived neurotrophic factor for treatment of diseases of the eye | |
| AU2002365511A1 (en) | Quinoline derivatives, process for preparing them and use for the treatment of diseases mediated by s-cd23 | |
| PT1625116E (pt) | Processo para a preparação de derivados de carboestirilo, tais como aripiprazole e seus intermediários | |
| EP1670894B8 (en) | Compositions including different types of transfer factor, methods for making the compositions, and methods of treatment using the compositions | |
| AU2002233407A1 (en) | 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof | |
| AU2002243778A1 (en) | Treatment of ppar mediated diseases | |
| AU2003245880A1 (en) | Process for the preparation of thioalkylamine derivatives | |
| AU2002311623A1 (en) | Process for the preparation of 1,4-dihydropyridines and novel 1,4-dihydropyridines useful as therapeutic agents | |
| AU2002246151A1 (en) | Azolylcarbynol derivatives of aryl (or heteroaryl) for the treatment of respiratory diseases | |
| AU2001277737A1 (en) | Novel substance having physiological activity, process for producing the same, and use | |
| AU2002329441A1 (en) | Process for the preparation of 3 - isochromanone | |
| AU2002221566A1 (en) | Novel benzimidazole derivatives for the treatment of gaba-alpha mediated disorders | |
| AU2002358085A1 (en) | Process for the preparation of 4-methyl-7-aminoquinolones | |
| AU2002333449A1 (en) | C2-substituted indane-1-ols and their derivatives, method for their production and their use as medicaments | |
| AU2002324291A1 (en) | Process for the preparation of beta-ionylideneacetaldehyde | |
| AU2002336085A1 (en) | C2-substituted Indane-1-ones and their derivatives, method for their production and their use as medicaments | |
| AU2002336983A1 (en) | C2-disubstituted Indane-1-ones and their derivatives, method for their production and their use as medicaments | |
| AU2002339519A1 (en) | Coniosulphides and their derivatives, method for their production and use as medicaments | |
| HK1067060A (en) | Quinazoline derivatives for the treatment of t cell mediated diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |